nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentagastrin—CCKBR—telencephalic ventricle—Parkinson's disease	0.178	0.448	CbGeAlD
Pentagastrin—CCKBR—forebrain—Parkinson's disease	0.0464	0.117	CbGeAlD
Pentagastrin—CCKBR—head—Parkinson's disease	0.0266	0.0669	CbGeAlD
Pentagastrin—CCKBR—nervous system—Parkinson's disease	0.0252	0.0634	CbGeAlD
Pentagastrin—CCKBR—central nervous system—Parkinson's disease	0.0243	0.0611	CbGeAlD
Pentagastrin—CCKBR—cerebellum—Parkinson's disease	0.0237	0.0597	CbGeAlD
Pentagastrin—CCKBR—brain—Parkinson's disease	0.0193	0.0485	CbGeAlD
Pentagastrin—CCKBR—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.0167	0.0277	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—GPR37—Parkinson's disease	0.0165	0.0274	CbGpPWpGaD
Pentagastrin—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Parkinson's disease	0.0153	0.0253	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.0149	0.0248	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—ADORA2A—Parkinson's disease	0.0139	0.023	CbGpPWpGaD
Pentagastrin—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—Parkinson's disease	0.013	0.0215	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.0129	0.0214	CbGpPWpGaD
Pentagastrin—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—Parkinson's disease	0.0129	0.0214	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—GRK5—Parkinson's disease	0.0127	0.021	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.0113	0.0188	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—DRD3—Parkinson's disease	0.0112	0.0186	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.0111	0.0184	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—PENK—Parkinson's disease	0.0106	0.0176	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—HTR7—Parkinson's disease	0.0102	0.0169	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—PDYN—Parkinson's disease	0.00972	0.0161	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—GRM5—Parkinson's disease	0.00915	0.0152	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—GPR37—Parkinson's disease	0.00843	0.014	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00819	0.0136	CbGpPWpGaD
Pentagastrin—BCHE—brainstem—Parkinson's disease	0.00748	0.0188	CbGeAlD
Pentagastrin—BCHE—forebrain—Parkinson's disease	0.00722	0.0182	CbGeAlD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00713	0.0118	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—HTR2A—Parkinson's disease	0.00712	0.0118	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00665	0.011	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.00657	0.0109	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00652	0.0108	CbGpPWpGaD
Pentagastrin—BCHE—cardiovascular system—Parkinson's disease	0.00611	0.0154	CbGeAlD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00602	0.00998	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00595	0.00987	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.0059	0.00978	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—GRM4—Parkinson's disease	0.00573	0.0095	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PENK—Parkinson's disease	0.00543	0.00901	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00528	0.00875	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00522	0.00866	CbGpPWpGaD
Pentagastrin—BCHE—medulla oblongata—Parkinson's disease	0.00522	0.0131	CbGeAlD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00516	0.00855	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00504	0.00836	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PDYN—Parkinson's disease	0.00497	0.00824	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00488	0.0081	CbGpPWpGaD
Pentagastrin—BCHE—midbrain—Parkinson's disease	0.00477	0.012	CbGeAlD
Pentagastrin—CCKBR—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00476	0.0079	CbGpPWpGaD
Pentagastrin—BCHE—spinal cord—Parkinson's disease	0.00465	0.0117	CbGeAlD
Pentagastrin—CCKBR—GPCR ligand binding—GRM5—Parkinson's disease	0.00462	0.00766	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00457	0.00759	CbGpPWpGaD
Pentagastrin—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—Parkinson's disease	0.00456	0.00757	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.00452	0.00749	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00447	0.00742	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00442	0.00733	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00442	0.00733	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00441	0.00731	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—DGKQ—Parkinson's disease	0.00432	0.00717	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GPR37—Parkinson's disease	0.00432	0.00717	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00432	0.00717	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—ATP6AP2—Parkinson's disease	0.00427	0.00707	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00418	0.00694	CbGpPWpGaD
Pentagastrin—BCHE—head—Parkinson's disease	0.00414	0.0104	CbGeAlD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00409	0.00679	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.004	0.00664	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00396	0.00656	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00393	0.00651	CbGpPWpGaD
Pentagastrin—BCHE—nervous system—Parkinson's disease	0.00392	0.00987	CbGeAlD
Pentagastrin—BCHE—Neuronal System—HCN3—Parkinson's disease	0.00379	0.00628	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00378	0.00628	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00378	0.00628	CbGpPWpGaD
Pentagastrin—BCHE—central nervous system—Parkinson's disease	0.00377	0.00951	CbGeAlD
Pentagastrin—BCHE—cerebellum—Parkinson's disease	0.00369	0.00929	CbGeAlD
Pentagastrin—CCKBR—GPCR downstream signaling—GRK5—Parkinson's disease	0.00361	0.00599	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00358	0.00594	CbGpPWpGaD
Pentagastrin—BCHE—Glycerophospholipid biosynthesis—PLA2G6—Parkinson's disease	0.00342	0.00567	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—HTR1A—Parkinson's disease	0.00341	0.00565	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—TAC1—Parkinson's disease	0.00335	0.00556	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—DRD1—Parkinson's disease	0.00329	0.00546	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GRK5—Parkinson's disease	0.00328	0.00544	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—GRM4—Parkinson's disease	0.00324	0.00537	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—DRD3—Parkinson's disease	0.00319	0.00528	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00318	0.00528	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00309	0.00513	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—VPS35—Parkinson's disease	0.00308	0.00511	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—PENK—Parkinson's disease	0.00307	0.00509	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00303	0.00502	CbGpPWpGaD
Pentagastrin—BCHE—brain—Parkinson's disease	0.003	0.00755	CbGeAlD
Pentagastrin—CCKBR—Signaling by GPCR—GRM4—Parkinson's disease	0.00294	0.00488	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—DRD2—Parkinson's disease	0.00288	0.00478	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—HTR7—Parkinson's disease	0.00288	0.00478	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—PDYN—Parkinson's disease	0.00281	0.00465	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PENK—Parkinson's disease	0.00279	0.00462	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00275	0.00456	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00265	0.0044	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—GRM5—Parkinson's disease	0.00261	0.00433	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DGKQ—Parkinson's disease	0.00255	0.00424	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GPR37—Parkinson's disease	0.00255	0.00424	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PDYN—Parkinson's disease	0.00255	0.00423	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—KCNJ4—Parkinson's disease	0.00244	0.00405	CbGpPWpGaD
Pentagastrin—BCHE—Phospholipid metabolism—PLA2G6—Parkinson's disease	0.00238	0.00395	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GRM5—Parkinson's disease	0.00237	0.00393	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00234	0.00388	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—EDN1—Parkinson's disease	0.00231	0.00383	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00222	0.00368	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00215	0.00357	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—DLG1—Parkinson's disease	0.00211	0.00349	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—RIT2—Parkinson's disease	0.00204	0.00339	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—HTR2A—Parkinson's disease	0.00202	0.00335	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00201	0.00334	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GRK5—Parkinson's disease	0.00194	0.00321	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00193	0.00319	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—TAC1—Parkinson's disease	0.0019	0.00314	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—DRD1—Parkinson's disease	0.00186	0.00308	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00183	0.00303	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—DRD3—Parkinson's disease	0.0018	0.00299	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00177	0.00294	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—HTR1A—Parkinson's disease	0.00175	0.0029	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GRM4—Parkinson's disease	0.00174	0.00288	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—TAC1—Parkinson's disease	0.00172	0.00286	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—DRD1—Parkinson's disease	0.00169	0.0028	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00168	0.00279	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—GRIK1—Parkinson's disease	0.00165	0.00273	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PENK—Parkinson's disease	0.00165	0.00273	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—MAG—Parkinson's disease	0.00165	0.00273	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—DRD3—Parkinson's disease	0.00164	0.00271	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—HTR7—Parkinson's disease	0.00163	0.0027	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—DRD2—Parkinson's disease	0.00163	0.0027	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00153	0.00253	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PDYN—Parkinson's disease	0.00151	0.0025	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—HTR7—Parkinson's disease	0.00148	0.00245	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—DRD2—Parkinson's disease	0.00148	0.00245	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GFAP—Parkinson's disease	0.00142	0.00235	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.0014	0.00233	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—GRIK2—Parkinson's disease	0.0014	0.00232	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GRM5—Parkinson's disease	0.0014	0.00232	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—SLC18A2—Parkinson's disease	0.00136	0.00225	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—EDN1—Parkinson's disease	0.0013	0.00216	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00129	0.00213	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—INS—Parkinson's disease	0.00126	0.00209	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00124	0.00206	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00123	0.00204	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—FGF20—Parkinson's disease	0.00123	0.00204	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00121	0.002	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—HSPA9—Parkinson's disease	0.00119	0.00198	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADORA2A—Parkinson's disease	0.00119	0.00197	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—EDN1—Parkinson's disease	0.00118	0.00196	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00118	0.00195	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00116	0.00193	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00114	0.00189	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—INSR—Parkinson's disease	0.0011	0.00182	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—CHRNA4—Parkinson's disease	0.00107	0.00178	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—FGB—Parkinson's disease	0.00104	0.00172	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—HTR2A—Parkinson's disease	0.00104	0.00172	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—HTR1A—Parkinson's disease	0.00103	0.00171	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TAC1—Parkinson's disease	0.00102	0.00169	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DRD1—Parkinson's disease	0.000997	0.00165	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000988	0.00164	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—HSPA8—Parkinson's disease	0.000985	0.00163	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000981	0.00163	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DRD3—Parkinson's disease	0.000966	0.0016	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—DLG4—Parkinson's disease	0.000924	0.00153	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—GRIN2B—Parkinson's disease	0.000903	0.0015	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADRBK1—Parkinson's disease	0.000902	0.0015	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—SLC6A3—Parkinson's disease	0.00089	0.00148	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DRD2—Parkinson's disease	0.000874	0.00145	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—HTR7—Parkinson's disease	0.000874	0.00145	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—RPL6—Parkinson's disease	0.000849	0.00141	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.000805	0.00134	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000767	0.00127	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—COMT—Parkinson's disease	0.000757	0.00126	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—MAOA—Parkinson's disease	0.000751	0.00125	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—DCTN1—Parkinson's disease	0.000737	0.00122	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IGF2—Parkinson's disease	0.000732	0.00121	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ND3—Parkinson's disease	0.000723	0.0012	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—MCCC1—Parkinson's disease	0.000723	0.0012	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IGF1R—Parkinson's disease	0.000708	0.00117	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—EDN1—Parkinson's disease	0.000699	0.00116	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—TALDO1—Parkinson's disease	0.000679	0.00113	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—OMD—Parkinson's disease	0.000679	0.00113	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—NDUFB11—Parkinson's disease	0.000644	0.00107	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—RPL23A—Parkinson's disease	0.000644	0.00107	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—RPL14—Parkinson's disease	0.000644	0.00107	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—NGF—Parkinson's disease	0.000643	0.00107	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GCH1—Parkinson's disease	0.000614	0.00102	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—HTR2A—Parkinson's disease	0.000612	0.00101	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—RPS8—Parkinson's disease	0.0006	0.000996	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—APOE—Parkinson's disease	0.000569	0.000943	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000554	0.000919	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—FBP1—Parkinson's disease	0.000548	0.000908	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GBA—Parkinson's disease	0.000548	0.000908	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—DBH—Parkinson's disease	0.000548	0.000908	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—INS—Parkinson's disease	0.000486	0.000806	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—DDC—Parkinson's disease	0.000402	0.000667	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GSTA4—Parkinson's disease	0.00038	0.00063	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000375	0.000622	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—CASP3—Parkinson's disease	0.000362	0.0006	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—IL6—Parkinson's disease	0.000359	0.000596	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	0.000358	0.000594	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PLA2G6—Parkinson's disease	0.000342	0.000567	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—MAOB—Parkinson's disease	0.000338	0.000561	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—MAPK8—Parkinson's disease	0.000332	0.000551	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000322	0.000534	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CYP2D6—Parkinson's disease	0.000251	0.000417	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CTGF—Parkinson's disease	0.000247	0.000409	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—INS—Parkinson's disease	0.000238	0.000394	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CYP2E1—Parkinson's disease	0.00023	0.000381	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—NQO1—Parkinson's disease	0.000227	0.000377	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—TH—Parkinson's disease	0.000224	0.000372	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CYCS—Parkinson's disease	0.000215	0.000357	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IL6—Parkinson's disease	0.000212	0.000352	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—COMT—Parkinson's disease	0.000191	0.000316	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GSTP1—Parkinson's disease	0.00019	0.000315	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—MAOA—Parkinson's disease	0.000189	0.000314	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—HMOX1—Parkinson's disease	0.000187	0.00031	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ABCB1—Parkinson's disease	0.00018	0.000298	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GSTM1—Parkinson's disease	0.000174	0.000289	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GPX1—Parkinson's disease	0.000167	0.000277	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—MTHFR—Parkinson's disease	0.000154	0.000255	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—APOE—Parkinson's disease	0.000143	0.000238	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—INS—Parkinson's disease	0.000123	0.000203	CbGpPWpGaD
